Clinical Trial Update: Drug Interaction Study With a Potential Alzheimer's Disease Compound [Phase 1]

View source ↗

Summary

Phase 1 drug interaction study involving a potential Alzheimer's disease compound; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Alzheimer Disease | Phase 1 | Status: COMPLETED